Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|October 8, 1999
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in childrenJ Swanson, S Gupta, D Guinta, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Assessment of coenzyme Q10 tolerability in Huntington's diseaseA Feigin, K Kieburtz, P Como, et al.Acta Neuropathologica|October 1, 1996
Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentationA Rubio, K Steinberg, D A Figlewicz, et al.Annals of Neurology|June 1, 1988
Duodenal and gastric delivery of levodopa in parkinsonismR Kurlan, J G Nutt, W R Woodward, et al.Annals of Neurology|March 1, 1989
A controlled clinical trial of baclofen as protective therapy in early Huntington's diseaseI Shoulson, C Odoroff, D Oakes, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Functional decline in Huntington's diseaseA Feigin, K Kieburtz, K Bordwell, et al.Neurology|March 26, 2003
Predictors of nursing home placement in Huntington diseaseV L Wheelock, T Tempkin, K Marder, et al.Neurology|October 1, 1990
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study GroupJ Jankovic, M McDermott, J Carter, et al.Journal of Huntington'S Disease|July 27, 2014
Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10K M Biglan, E R Dorsey, R V V Evans, et al.Archives of Neurology|August 1, 1988
Cerebrospinal fluid correlates of depression in Huntington's diseaseR Kurlan, E Caine, A Rubin, et al.Pageof 11